Julio Martín
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Gastroenterology top 10%
- Epidemiology top 10%
- Trypanosoma species research and implications 14
- Liver Disease Diagnosis and Treatment 4
-
- Research on Leishmaniasis Studies 13
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Synthesis and Biological Evaluation 5
-
- Glycosylation and Glycoproteins Research 3
- Protein Structure and Dynamics 3
Julio Martín
47 papers receiving 728 citations
Peers
Comparison fields: 5 of 87
- Hepatology 95
- Gastroenterology 65
- Epidemiology 281
- Public Health, Environmental and Occupational Health 197
- Radiology, Nuclear Medicine and Imaging 150
Countries citing papers authored by Julio Martín
This map shows the geographic impact of Julio Martín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julio Martín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julio Martín more than expected).
Fields of papers citing papers by Julio Martín
This network shows the impact of papers produced by Julio Martín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julio Martín. The network helps show where Julio Martín may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Julio Martín, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 9 | |
| 2 | 2021 | 16 | |
| 3 | 2018 | 13 | |
| 4 | 2018 | 36 | |
| 5 | 2016 | 23 | |
| 6 | 2013 | 18 | |
| 7 | 2011 | 4 | |
| 8 | 2009 | 26 | |
| 9 | 2006 | 34 | |
| 10 | 2003 | 12 | |
| 11 | 2000 | 4 | |
| 12 | Secuencias ultrarrápidas single shot T2 en eco del espín: aplicaciones en patología abdominopélvica. | 1999 | 1 |
| 13 | 1998 | 23 | |
| 14 | 1996 | 32 | |
| 15 | 1994 | 10 | |
| 16 | 1993 | 4 | |
| 17 | 1990 | 3 | |
| 18 | 1990 | 23 | |
| 19 | Evidence of a pH-dependent conformational change at the active site of lysolecithin:lysolecithin acyltransferase from rabbit lung. | 1989 | 2 |
| 20 | 1989 | 9 |
About Julio Martín
Julio Martín is a scholar working on Hepatology, Epidemiology and Gastroenterology, having authored 47 papers that have together received 747 indexed citations. Recurring topics across this work include Trypanosoma species research and implications (14 papers), Research on Leishmaniasis Studies (13 papers), Synthesis and Biological Evaluation (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Protein Structure and Dynamics (3 papers). The work is most often cited by research in Hepatology (95 citations), Gastroenterology (65 citations) and Epidemiology (281 citations). Julio Martín has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include L. Donoso, Jordi Puig, Melcior Sentís, J. Falcó, María Rosa Bella, Imanol Peña, Anna Darnell, Juan Cantizani, Jesús Pérez‐Gil and Jesús Herránz. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.